Setmelanotide for the Treatment of Acquired Hypothalamic Obesity

New England Journal of Medicine · Published 2026-07-08 · DOI 10.1056/nejmoa2512275

Free full text

Authors (33)

Jennifer L. Miller, Hanneke M. van Santen, Susan A. Phillips, Jill Hamilton, Jens Aberle, Thozhukat Sathyapalan, Zainaba Mohamed, Shana E. McCormack, Ashley H. Shoemaker, Megan M. Kelsey, Luma Ghalib, Guenter Stalla, Vidhu V. Thaker, Reema Habiby, Katie Larson Ode, Martin Wabitsch, Mehul Dattani, M. Jennifer Abuzzahab, Hussein Abdullatif, Ryan Morgan, Margaret Stefater-Richards, Vanita R. Aroda, Carsten Friedrich, Joan C. Han, Hiraku Ono, Keisuke Nagasaki, Tomohiro Tanaka, Tsuyoshi Isojima, Hiroshi Arima, Cecilia Scimia, Guojun Yuan, Hermann L. Müller, Christian L. Roth

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Miller, J., Santen, H., Phillips, S., et al. (2026). Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2512275

Related articles